Sinil Pharmaceutical Co., Ltd.

A012790

KR7012790002

Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 03:30:00 17/06/2024 am IST			5-day change	1st Jan Change
7,230 ^KRW	+0.14%		-0.41%	-6.23%

16/05	Sinil Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
2023	Sinil Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Sinil Pharmaceutical Co., Ltd.(KOSDAQ:A012790) dropped from S&P Global BMI Index

September 19, 2022 at 09:30 am IST

Latest news about Sinil Pharmaceutical Co., Ltd.

Sinil Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	16/05	CI
Sinil Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11	CI
Sinil Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/23/15	CI
Sinil Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/22/14	CI
Sinil Pharmaceutical Co., Ltd.(KOSDAQ:A012790) dropped from S&P Global BMI Index	19/22/19	CI
Sinil Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	16/22/16	CI
Sinil Pharmaceutical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	15/21/15	CI
Sinil Pharmaceutical Co., Ltd.(KOSDAQ:A012790) added to S&P Global BMI Index	20/21/20	CI
Jung Sung Hun and four four related parties acquired 7.19% stake in Shinil Pharmaceutical Co., Ltd..	08/15/08	CI
Midas International Asset Management acquired 5.13% stake in Shinil Pharmaceutical Co., Ltd..	23/15/23	CI

Chart Sinil Pharmaceutical Co., Ltd.

Duration

Period

More charts

SINIL PHARMACEUTICAL CO., LTD. is a Korea-based company engaged in the manufacture of pharmaceuticals. The Companyâs products consist of antihyperlipidemic agents, antitussives, expectorants, anti-antipyretic agents, analgesic agents, inflammatory agents, dermatological treatments, chemotherapeutic agents, antihistamines, antihypertensives and mixed vitamins, among others. It also engages in the leasing of real estate.

Sector

Pharmaceuticals

Calendar

14/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
SINIL PHARMACEUTICAL CO., LTD.	-6.23%	5.95Cr
SUN PHARMACEUTICAL INDUSTRIES LTD.	+20.76%	4.35TCr
OTSUKA HOLDINGS CO., LTD.	+18.62%	2.15TCr
SANDOZ GROUP AG	+18.33%	1.53TCr
CIPLA LIMITED	+26.36%	1.51TCr
ZYDUS LIFESCIENCES LIMITED	+56.55%	1.34TCr
THE MEDICINES COMPANY	-0.05%	678.76Cr
ONO PHARMACEUTICAL CO., LTD.	-14.94%	637.58Cr
STADA ARZNEIMITTEL	-8.87%	572.55Cr
ASPEN PHARMACARE HOLDINGS LIMITED	+8.17%	536.13Cr